E-mail this story
FDA rewrites opioid narcotic labels to tighten use for pain
Patients should not be prescribed long-acting or extended-release opioid pain relievers unless they need daily, round-the-clock treatment of their pain that can’t be managed by any other means, the Food and Drug Administration has told physicians.
By Melissa Healy
September 10, 2013